PATENT CLAIM ANALYSIS

Application Number: 15922273
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2019-02
Patent Classification: ["514", "161000"]

Abstract:
The present invention provides hepatoprotectant acetaminophen mutual prodrugs, which have an acetaminophen moiety covalently linked to a second moiety that may act as a hepatoprotectant against acetaminophen hepatotoxicity. Additionally, acetaminophen mutual prodrugs may have improved water solubility which may provide better suitability for parenteral and other dosage forms relative to administration of acetaminophen. Also provided are methods of treating a disease or condition that is responsive to acetaminophen (such as fever, pain and ischemic injury) using hepatoprotectant acetaminophen mutual prodrugs, as well as kits and unit dosages.

Claim (Index 72):
A formulation comprising the compound of  claim 41 , or a pharmaceutically acceptable salt thereof or solvate of the foregoing, and a compound selected from the group consisting of an opioid, non-steroidal anti-inflammatory drug (NSAID), benzodiazepine, and barbiturate.

Metadata:
- Claim Count in Document: 29.0
- Percentile: 90.0
- Lexical Diversity: 1.52381
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15150099', '14346689', '12993089', '15592048', '14252683']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7589714568072159
- 35 USC 102 Novelty (BERT): 0.5617962446599611
- Combined Prediction Score: 0.7392539355924904
- Mean Citation Score: 302.860074
- Max Citation Score: 454.29565
- Similarity Product: 353.3672246028662

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test